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genotypes, it was slightly overrepre-
sented in AFLP cluster IVb (CC 121)
compared with major clusters I and
III. Whether the prevalence of PVL in
carriage- and blood-culture isolates is
higher and differs among distinct
genetic clusters of S. aureus in coun-
tries with endemic CA-MRSA has to
be investigated further.
In conclusion, we have shown that
the PVL-encoding phage has entered
distinct staphylococcal lineages,
although its prevalence differs per
clonal group. PVL is associated with
skin and soft tissue infections but not
with bacteremia, which suggests that
PVL is not likely to be involved in the
pathogenesis of bacteremia.
Infections caused by PVL-positive S.
aureus strains have been documented
since the 1930s. Expansion and
increased incidence of such infec-
tions, however, are more recent, and
further epidemiologic studies for
tracking this phenomenon are still
warranted.
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Small Anellovirus
in Hepatitis C
Patients and
Healthy Controls
To the Editor: Torquetenovirus
(TTV) and torquetenominivirus
(TTMV) are characterized by a small,
negative-sense, circular, single-
stranded DNA genome and by an
extraordinary ability to produce
chronic plasma viremia. Indeed,
>80% of humans harbor variably high
viral loads of TTV, TTMV, or both, in
plasma, regardless of geographic
provenance, age, sex, and health con-
ditions (1). Currently, TTV and
TTMV are classified as distinct
species in the floating (although
closely linked to the family
Circoviridae) genus Anellovirus, but
their extreme genetic heterogeneity
and some distinctive features in
genomic organization have led some
to suggest that they should be classi-
fied as an independent family (2,3).
Most recently, after examining serum
specimens from patients with symp-
toms of an acute viral infection by
using DNase sequence-independent
single-primer amplification, Jones et
al. (4) identified, among other viruses,
2 novel TTV- and TTMV-like agents.
Because of their even smaller
genomes (≈2.4 and 2.6 kb vs. 3.6–3.8
kb for TTV and 2.8–2.9 kb for
TTMV), these agents were named
small anelloviruses (SAVs).
Because tissue culture and sero-
logic methods are not yet available,
diagnosis of anellovirus infection
relies exclusively on viral DNA
detection. We tested 55 Italian hepati-
tis C patients (mean age 56 ± 14
years, male/female ratio 30/25, 53
TTV positive) and, for comparison,
35 healthy donors (mean age 36 ± 12
years, male/female ratio 17/18, 33
TTV positive) for SAV in plasma by
using the polymerase chain reaction
(PCR) primers described by Jones et
al. (4), followed by direct amplicon
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sequencing. To increase assay sensi-
tivity, a heminested PCR format was
adopted that used a sense primer
designed in a segment of the untrans-
lated region that is highly conserved
among all anelloviruses (5′-
TCAAGGGGCA ATTCGGGCT-3′).
We found 5 positive results among the
hepatitis C patients (9.1%, all of
whom were TTV positive) and 3 pos-
itive results among healthy controls
(8.6%); and all were confirmed by
sequence data.
The amino acid sequences inferred
from the coding segment of the ampli-
con of SAV in this study and the cor-
responding sequences of the 10 SAV
in GenBank at the time of this writing
were then aligned with representative
TTV and TTMV sequences (online
Appendix Figure 1, available from
http://www.cdc.gov/ncidod/EID/vol1
2no07/06-0234-G1.htm). This method
allowed us to identify the motif
WX7HX3CXCX5H, which is highly
characteristic of the open reading
frame 2 (ORF2) of anelloviruses (5),
in all SAVs. SAV sequences, as well
as a large number of TTVs and all
TTMVs, were then used to construct a
phylogenetic tree and to calculate the
extent of genetic divergence within
SAV, TTV, and TTMV. Although a
precise phylogenetic description will
require the analysis of full-length
ORF2, the SAV sequences clustered
quite separately from those of TTV
and TTMV, and the extent of diver-
gence observed among SAV was huge
and in the same range as among TTV
or TTMV. Furthermore, SAVs
obtained from hepatitis C patients and
healthy participants were intermin-
gled (online Appendix Figure 2, avail-
able from http://www.cdc.gov/ncidod/
EID/vol12no07/06-0234-G2.htm).
While this study was under way,
Biagini et al. reported a 12% preva-
lence of SAV viremia in French blood
donors (6). Our results confirm the
high prevalence of SAV viremia in
healthy persons and extend the find-
ing to hepatitis C patients. Our data,
combined with those of Biagini et al.,
indicate that, since SAV clusters sepa-
rately from previously identified
anelloviruses, it should be considered
a distinct species (or possibly genus).
This would increase the already high
genetic diversity of anelloviruses, fur-
ther arguing for the appropriateness of
creating a separate viral family.
Because the clinical and viral
parameters of hepatitis C in SAV-pos-
itive patients were not significantly
different from those in the SAV-nega-
tive patients (data not shown), our
results suggest that, similar to TTV
(7), SAV has little or no effect on the
course of hepatitis C. Although
anelloviruses have not yet been defi-
nitely linked to any specific disease,
evidence is growing that they might
be involved in acute respiratory dis-
eases in children (8,9). Furthermore, a
florid TTV replication in the respira-
tory tract correlated with severity of
lung impairment in children with
asthma (10). Aprecise appreciation of
the wide range of viruses classified
within the anelloviruses is a prerequi-
site to understanding such disease
associations and the disease-inducing
potential of these viruses in general.
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